Detalhe da pesquisa
1.
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
Lancet Oncol
; 18(11): 1532-1542, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29033099
2.
Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants.
Cancer Res
; 70(16): 6527-36, 2010 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20663906